HMN Financial Inc
Change company Symbol lookup
Select an option...
HMNF HMN Financial Inc
BAM Brookfield Asset Management Inc
XOM Exxon Mobil Corp
NEWR New Relic Inc
T AT&T Inc
AICAF Air China Ltd
JNJ Johnson & Johnson
TIP iShares TIPS Bond ETF
OCUL Ocular Therapeutix Inc

Financials : Thrifts & Mortgage Finance | Small Cap Value
Company profile

HMN Financial, Inc. (HMN) is a stock savings bank holding company that owns Home Federal Savings Bank (the Bank). The Bank operates retail banking and loan production facilities in Minnesota, Iowa and Wisconsin. The Bank has two subsidiaries, Osterud Insurance Agency, Inc., which offers financial planning products and services, and HFSB Property Holdings, LLC, which acts as an intermediary for the Bank in holding and operating certain foreclosed properties. HMN's business involves attracting deposits from the general public and businesses and using such deposits to originate or purchase one- to four-family residential, commercial real estate and multi-family mortgage loans, among others. HMN invests in mortgage-backed and related securities, the United States government agency obligations and other permissible investments. HMN serves the southern Minnesota counties of Dodge, Fillmore, Freeborn, Houston, Mower, Olmsted and Winona, and portions of Steele, Goodhue and Wabasha.

Closing Price
Day's Change
0.10 (0.75%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Oncology Drugs Market to Exhibit a CAGR of 11.6% by 2027; Ongoing Clinical Trials to Brighten Growth Prospects, states Fortune Business Insights(TM)

11:36 am ET August 11, 2020 (Globe Newswire) Print

The global oncology drugs market size is expected to reach USD 394.24 billion by 2027, exhibiting a CAGR of 11.6% during the forecast period. The growing prevalence of cancer around the world will spur opportunities for this market during the forecast period, states Fortune Business Insights, in a report, titled "Oncology Drugs Market Size, Share & COVID-19 Impact Analysis, By Drugs Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, and Others), By Therapy (Chemotherapy, Targeted Therapy, and Immunotherapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, and Others), By Dosage Form (Solid, Liquid, and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), and Regional Forecast, 2020-2027." The market size stood at USD 141.33 billion in 2019.

The oncology drugs market highlights:

-- An extensive study of regions

-- Forecast value of the market

-- Detailed analysis of the segments

-- COVID-19 effect on the market

-- Ongoing clinical trials

Request a Sample Copy of the Research Report:

Market Driver:

Surging Pharmaceutical Industry to Contribute Colossal Development

The ongoing technological advancement in the field of pharmacy is expected to create opportunities for the market during the forecast period. The clinical trials and various drugs in the pipeline can further facilitate the healthy growth of the industry. The growing cases of numerous types of cancer, such as lung cancer, skin cancer, prostate cancer, colon cancer, breast cancer, and others will spur demand for oncology drugs, thus enhancing market growth. According to the World Health Organization (WHO), cancer is a growing burden and the number of new cancer cases is going to rise from 18.1 million in 2018 to 29.4 million by 2040. Moreover, product launches and approvals are expected to have a tremendous impact on the market.

The whole world is fighting the novel coronavirus. Sectors and industries are devasted due to the major loss caused by COVID-19 in business. The authorities of several countries have initiated lockdown to prevent the spread of this deadly virus. Such plans have caused disturbances in the production and supply chain. But, with time and resolution, we will be able to combat this stern time and get back to normality. Our well-revised reports will help companies to receive in-depth information about the present scenario of every market so that you can adopt the necessary strategies accordingly.

To get to know more about the short-term and long-term impacts of COVID-19 on this market,

please visit:

Positive Impact on Oncology Drugs Market Growth During COVID-19

The outbreak of COVID-19 has had a positive impact on the oncology drugs market globally. Certain market segments have witnessed a growth in demand for drugs with respect to the COVID-19 emergency. Panic buying of medications has been witnessed among the cancer patients amid lockdown.

The pharmaceutical companies involved in this market have significantly improved their supply chain management, enhanced the capabilities of their R&D, and invested more their manufacturing management and quality control. For instance, according to the quarterly reports of 2020 of Roche, their global supply chain of medicines and tests remain intact and their pharmaceutical division sales increased by 7% as compared to the prior year.

Regional Analysis:

Rising Prevalence to Cancer to Influence Market in North America

The market size in North America is expected to witness a rapid growth rate during the forecast period. The dominance in the region is attributed to the growing prevalence of cancer in the U.S. As per the National Cancer Institute, in 2020, approximately 1.8 million people will be diagnosed with cancer in the U.S.

The recent product launches will aid the expansion of the market in the region. Europe is predicted to exhibit a stellar growth rate during the forecast period owing to the growing cancer burden in countries such as U.K., Germany, and France. The market in Asia Pacific is predicted to rise tremendously during the forecast period due to the rising awareness among the population regarding cancer.

Quick Buy - Oncology Drugs Market Research Report:

Key Development:

April 2019: Sun Pharmaceutical Industries announced the release of INFUGEM injection, which will ve used for the treatment of cancer in the US.

List of the Leading Companies Operating in the Oncology Drugs Market are:

-- F. Hoffmann-La Roche Ltd (Basel, Switzerland)

-- Genentech, Inc. (California, United States)

-- Novartis AG (Basel, Switzerland)

-- Pfizer Inc. (New York, United States)

-- Bristol-Myers Squibb Company (New York, United States)

-- GlaxoSmithKline plc. (Brentford, United Kingdom)

-- Eli Lilly and Company (Indiana, United States)

-- AstraZeneca (Cambridge, United Kingdom)

-- Sanofi (Paris, France)

-- Bayer AG (Leverkusen, Germany)

-- Other Players

Have Any Query? Ask Our Experts:

Detailed Table of Content:

-- Introduction

    -- Research Scope

    -- Research Scope

    -- Market Segmentation

    -- Research Methodology

    -- Definitions and Assumptions

    -- Executive Summary

    -- Market Dynamics

      -- Market Drivers

      -- Market Drivers

      -- Market Restraints

      -- Market Opportunities

      -- Key Insights

        -- Prevalence of Key Indications (Lung Cancer, Breast Cancer, Prostate Cancer, etc.), By Region/Country

        -- Prevalence of Key Indications (Lung Cancer, Breast Cancer, Prostate Cancer, etc.), By Region/Country

        -- Overview of Different Oncology Drugs with respect to Regulatory Approvals and Clinical Trials

        -- Pricing Analysis, By Key Players

        -- Recent Advancements in Development of Oncology Drugs

        -- Key Industry Developments (Mergers, Acquisitions, and Partnerships)

        -- Impact of COVID-19 on Oncology Drugs Market

        -- Global Oncology Drugs Market Analysis, Insights and Forecast, 2016-2027

          -- Key Findings / Summary

          -- Key Findings / Summary

          -- Market Analysis, Insights and Forecast - By Drug Class

            -- Cytotoxic Drugs

              -- Cytotoxic Drugs

                -- Alkylating Agents

                -- Antimetabolites

                -- Others

                -- Targeted Drugs

                  -- Monoclonal Antibodies

                  -- Monoclonal Antibodies

                  -- Others

                  -- Hormonal Drugs

                  -- Others

                  -- Market Analysis, Insights and Forecast - By Therapy

                    -- Chemotherapy

                    -- Chemotherapy

                    -- Targeted Therapy

                    -- Immunotherapy

                    -- Market Analysis, Insights and Forecast - By Indication

                      -- Lung Cancer

                      -- Lung Cancer

                      -- Stomach Cancer

                      -- Colorectal Cancer

                      -- Breast Cancer

                      -- Prostate Cancer

                      -- Others

                      -- Market Analysis, Insights and Forecast - By Dosage Form

                        -- Solid

                          -- Tablets

                          -- Capsules

                          -- Liquid

                          -- Injectable

                            -- Prefilled Syringes

                            -- Prefilled Syringes

                            -- Others

                            -- Market Analysis, Insights and Forecast- By Distribution Channel

                              -- Hospital Pharmacies

                              -- Hospital Pharmacies

                              -- Retail Pharmacies

                              -- Online Pharmacies

                              -- Others

                              -- Market Analysis, Insights and Forecast - By Region

                                -- North America

                                -- North America

                                -- Europe

                                -- Asia Pacific

                                -- Latin America

                                -- Middle East & Africa

                                TOC Continued...!!!

                                Request for Customization:

                                Have a Look at Related Reports:

                                Lung Cancer Therapeutics Market Size, Share and Global Trend By Therapy (Targeted, Therapy, Immunotherapy, Chemotherapy), By Cancer Type (Non-small cell lung cancer (NSCLC), Small cell lung cancer (SCLC)), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography Forecast till 2026

                                Breast Cancer Therapeutics Market Size, Share and Global Trend By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Cancer Type (Hormone Receptor, HER2+), and Geography Forecast till 2026

                                Stomach Cancer/Gastric Cancer Treatment Market Size, Share & Industry Analysis, By Drug Type (Programmed Cell Death Protein 1 (PD-1) Inhibitors, Human Epidermal Growth Factor Receptor (HER2) Antagonists, and Others), By Disease Indication (Gastric Adenocarcinoma, Gastrointestinal Stromal Tumor (GIST)), By Route of Administration (Oral and Parenteral) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) and Regional Forecast, 2019-2026

                                Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026

                                About Us:

                                Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

                                Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

                                At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

                                Contact Us:

                                Fortune Business Insights(TM) Pvt. Ltd.

                                308, Supreme Headquarters,

                                Survey No. 36, Baner,

                                Pune-Bangalore Highway,

                                Pune - 411045, Maharashtra, India.


                                US :+1 424 253 0390

                                UK : +44 2071 939123

                                APAC : +91 744 740 1245


                                Fortune Business Insights(TM)

                                LinkedIn | Twitter | Blogs

                                Press Release:


                                comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.